Literature DB >> 22795804

Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.

Chiaojung Jillian Tsai1, Theresa M Hofstede, Erich M Sturgis, Adam S Garden, Mary E Lindberg, Qingyi Wei, Susan L Tucker, Lei Dong.   

Abstract

PURPOSE: To determine the association between radiation doses delivered to the mandible and the occurrence of osteoradionecrosis (ORN). METHODS AND MATERIALS: We reviewed the records of 402 oropharyngeal cancer patients with stage T1 or T2 disease treated with definitive radiation between January 2000 and October 2008 for the occurrence of ORN. Demographic and treatment variables were compared between patients with ORN and those without. To examine the dosimetric relationship further, a nested case-control comparison was performed. One to 2 ORN-free patients were selected to match each ORN patient by age, sex, radiation type, treatment year, and cancer subsite. Detailed radiation treatment plans for the ORN cases and matched controls were reviewed. Mann-Whitney test and conditional logistic regression were used to compare relative volumes of the mandible exposed to doses ranging from 10 Gy-60 Gy in 10-Gy increments.
RESULTS: In 30 patients (7.5%), ORN developed during a median follow-up time of 31 months, including 6 patients with grade 4 ORN that required major surgery. The median time to develop ORN was 8 months (range, 0-71 months). Detailed radiation treatment plans were available for 25 of the 30 ORN patients and 40 matched ORN-free patients. In the matched case-control analysis, there was a statistically significant difference between the volumes of mandible in the 2 groups receiving doses between 50 Gy (V50) and 60 Gy (V60). The most notable difference was seen at V50, with a P value of .02 in the multivariate model after adjustment for the matching variables and dental status (dentate or with extraction).
CONCLUSIONS: V50 and V60 saw the most significant differences between the ORN group and the comparison group. Minimizing the percent mandibular volume exposed to 50 Gy may reduce ORN risk.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22795804     DOI: 10.1016/j.ijrobp.2012.05.032

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  58 in total

Review 1.  Revisiting the dose constraints for head and neck OARs in the current era of IMRT.

Authors:  N Patrik Brodin; Wolfgang A Tomé
Journal:  Oral Oncol       Date:  2018-09-08       Impact factor: 5.337

2.  Treatment outcome of ion beam therapy in eight patients with head and neck cancers.

Authors:  Jun-Ichi Ohkubo; Nobusuke Hohchi; Shoko Takeuchi; Shoji Ikezaki; Yasuhiro Kise; Hiroki Koizumi; Hideaki Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-11       Impact factor: 2.503

3.  Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.

Authors: 
Journal:  Radiother Oncol       Date:  2017-07-18       Impact factor: 6.280

4.  Cause and occurrence timing of osteoradionecrosis of the jaw: a retrospective study focusing on prophylactic tooth extraction.

Authors:  Satoshi Wanifuchi; Masaya Akashi; Yasuo Ejima; Hirotaka Shinomiya; Tsutomu Minamikawa; Shungo Furudoi; Naoki Otsuki; Ryohei Sasaki; Ken-Ichi Nibu; Takahide Komori
Journal:  Oral Maxillofac Surg       Date:  2016-07-11

5.  Restorative aspects of oral cancer reconstruction.

Authors:  C W Barclay; E C Foster; C L Taylor
Journal:  Br Dent J       Date:  2018-11-09       Impact factor: 1.626

6.  Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study.

Authors:  Pei-Hsun Liao; Chi-Hsiang Chu; Yao-Min Hung; Pei-Ling Tang; Tsu-Jen Kuo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

7.  Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis.

Authors:  Angela T T Wong; Stephen Y Lai; G Brandon Gunn; Beth M Beadle; Clifton D Fuller; Martha P Barrow; Theresa M Hofstede; Mark S Chambers; Erich M Sturgis; Abdallah Sherif Radwan Mohamed; Jan S Lewin; Katherine A Hutcheson
Journal:  Oral Oncol       Date:  2017-01-21       Impact factor: 5.337

Review 8.  Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group report.

Authors:  Karen E Effinger; Cesar A Migliorati; Melissa M Hudson; Kevin P McMullen; Sue C Kaste; Kathy Ruble; Gregory M T Guilcher; Ami J Shah; Sharon M Castellino
Journal:  Support Care Cancer       Date:  2014-04-30       Impact factor: 3.603

9.  The association with xerostomia from sialadenitis and the jaw osteonecrosis in head and neck cancer population: a nationwide cohort study.

Authors:  Yi-Fang Huang; Chih-Hsin Muo; Chun-Hao Tsai; Shih-Ping Liu; Chung-Ta Chang
Journal:  Clin Oral Investig       Date:  2018-05-03       Impact factor: 3.573

10.  Osteoradionecrosis in patients with salivary gland malignancies.

Authors:  J Rhet Tucker; Li Xu; Erich M Sturgis; Abdallah S R Mohamed; Theresa M Hofstede; Mark S Chambers; Stephen Y Lai; Clifton David Fuller; Beth Beadle; G Brandon Gunn; Katherine A Hutcheson
Journal:  Oral Oncol       Date:  2016-03-31       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.